Condition
Delayed Platelet Engraftment
Total Trials
4
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
P 1 (1)
P 2 (1)
P 4 (1)
Trial Status
Unknown2
Recruiting2
Clinical Trials (4)
Showing 4 of 4 trials
NCT07321626Phase 1Recruiting
Romiplostim N01 for Platelet Recovery After Haploidentical HSCT
NCT06818916Not ApplicableRecruitingPrimary
Hetrombopag in Promoting Platelet Engraftment After Auto-HSCT in Children With Neuroblastoma
NCT01379391Phase 4Unknown
Efficacy and Safety of rHuTPO on Platelet Engraftment After Allo-HSCT
NCT02240992Phase 2Unknown
MSCs With or Without Peripheral Blood Stem Cell for Treatment of Poor Graft Function and Delayed Platelet Engraftment
Showing all 4 trials